Abbott Laboratories

Yahoo Finance • 5 hours ago

Abbott’s Whoop Investment Puts Digital Health Wearables On Shareholders’ Radar

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) has invested in Whoop's US$575m Series G funding round as a strateg... Full story

Yahoo Finance • 15 hours ago

Best Healthcare Stocks to Buy Right Now for Long-Term Growth

Stocks that perform well over the long run tend to have several traits, such as a large, growing market where they have a strong presence, solid financial results, and a competitive moat. Investing in companies that fit that description an... Full story

Yahoo Finance • yesterday

Whoop Raises $575 Million at $10.1 Billion Valuation, Reports 103% Growth

This article first appeared on GuruFocus. Whoop Inc. is pushing closer to the public markets with a fresh capital injection that underscores growing investor conviction in subscription-driven health platforms. The Boston-based wearable co... Full story

Yahoo Finance • 2 days ago

MiniMed gains as Wall Street issues bullish views on the Medtronic unit

[Wall street] MiniMed (MNMD) shares gained for the first time in five sessions on Tuesday as Medtronic’s (MDT [https://seekingalpha.com/symbol/MDT]) diabetes business received multiple bullish views on Wall Street as its post-IPO quiet pe... Full story

Yahoo Finance • 2 days ago

Whoop’s valuation just tripled to $10 billion

Image Credits:Whoop Whoop, the fitness and health tracking wearable company, has closed a $575 million Series G funding round at a $10.1 billion valuation — nearly triple its last reported valuation of $3.6 billion — in a deal that brings... Full story

Yahoo Finance • 2 days ago

Whoop CEO after raising $575 million: Our next step is an IPO

Next step for Whoop (WHOO.PVT): a healthy IPO day. The wearable device company — which dubs itself a "human performance company" — said Tuesday it raised $575 million in Series G funding at a $10.1 billion valuation. Rival Oura Health, ma... Full story

Yahoo Finance • 2 days ago

Whoop valuation tops $10B, setting up highly anticipated IPO

Whoop valuation tops $10B, setting up highly anticipated IPO Proactive uses images sourced from Shutterstock Boston-based wearable company Whoop has raised $575 million in new funding, boosting its valuation to over $10 billion, roughly t... Full story

Yahoo Finance • 2 days ago

Global Medical Nutrition Market to Reach USD 31.1 Billion by 2035, Driven by Preventive Healthcare Across North America, Europe & Asia-Pacific - Key Players Nestlé, Abbott, Danone & DSM Lead Innovation

Rising chronic diseases, aging population, and personalized nutrition trends accelerate demand for therapeutic nutrition across hospitals, clinics, and home care settings NEWARK, Del., March 31, 2026 /PRNewswire/ -- According to a latest... Full story

Yahoo Finance • 2 days ago

Abbott integrates Precision Oncology portfolio into Flatiron’s OncoEMR

Abbott (ABT) and Flatiron Health announced the integration of Abbott’s comprehensive Precision Oncology portfolio into OncoEMR, Flatiron’s cloud-based Electronic Medical Record platform. Through this integration, oncology providers can now... Full story

Yahoo Finance • 2 days ago

Apple watch rival Whoop is raising $575 million from investors including Cristiano Ronaldo, LeBron James

Whoop (WHOO.PVT) doesn't appear to be running toward an IPO, but it got another healthy injection of capital. The wearable device company — which dubs itself a "human performance company" — said Tuesday it raised $575 million in Series G... Full story

Yahoo Finance • 2 days ago

WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform

WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform Round Led by Collaborative Fund with Participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo C... Full story

Yahoo Finance • 3 days ago

Will Integrating Precision Oncology Tests into OncoEMR Change Abbott Laboratories' (ABT) Narrative?

Abbott and Flatiron Health recently integrated Abbott's Precision Oncology portfolio into Flatiron's OncoEMR platform, allowing more than 1,600 community cancer centers and 4,700 providers to order and receive results for tests such as Onc... Full story

Yahoo Finance • 3 days ago

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Broadens access to Abbott's Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers in Flatiron's North America network, helping accelerate informed treatment decisions Allows oncologists to order... Full story

Yahoo Finance • 3 days ago

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

Key Points The Schwab U.S. Dividend Equity ETF recently completed its annual reconstitution. It added two new healthcare stocks to its top 10. Healthcare is now its second-largest sector. 10 stocks we like better than Schwab U.S. Dividend... Full story

Yahoo Finance • 6 days ago

Clinical Nutrition for Diabetes Care Market Report 2026-2030 Featuring Profiles of Key Players - Pfizer, Bayer, Sanofi-Aventis, Abbott Labs, Roche and More

Company Logo The rise of diabetes, demand for specialized nutrition, digital monitoring tools, and home-based management are key trends driving market growth Clinical Nutrition for Diabetes Care MarketClinical Nutrition for Diabetes Care... Full story

Yahoo Finance • 7 days ago

How Goode Foods went from family biz to viral brand

Andrew Johnson, CEO of Goode Foods, sits down with Host Elizabeth Gore for a candid conversation about second-generation entrepreneurship, resilience, and innovation in a legacy industry. Now at the helm, Andrew opens up about stepping int... Full story

Yahoo Finance • 7 days ago

Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now.On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, Abbott Laboratories (NYSE:ABT) is now a... Full story

Yahoo Finance • 7 days ago

Abbott hosts conference call for first-quarter earnings

ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earning... Full story

Yahoo Finance • 8 days ago

SCHD Annual Reconstitution: Here's What This Dividend ETF Looks Like Now

Every year in March, the Schwab U.S. Dividend Equity ETF(NYSEMKT: SCHD) reconstitutes and rebalances itself. This essentially means that it runs its strategic methodology from scratch and rebuilds its portfolio according to what's happenin... Full story

Yahoo Finance • 8 days ago

SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?

Quick Read Schwab U.S. Dividend Equity ETF (SCHD) removed 22 holdings including Valero Energy (VLO), up 80%, Halliburton (HAL), up 46.5%, and Ovintiv (OVV), up 32%, while adding UnitedHealth Group (UNH), down 48%, Ares Management (ARES),... Full story